Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

13 treatments under study, led by Actfocused Erp

Research Leaders

8 sponsors active, led by Mclean Hospital

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 6 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (6)

Trial Status

Completed4
Active Not Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (6)

Research Network

Common Treatments

  • Actfocused Erp1
  • Exposure And Response Prevention1
  • Inferencebased Cognitive Therapy1
  • Internetdelivered Combined Cognitive Bias Modification Icbmc1
  • Inactive Sham Approach Avoidance Training1

Active Sponsors

  • Mclean Hospital2
  • Utah State University1
  • Centre Hospitalier Henri Laborit1
  • BIXINK Therapeutics Co., Ltd.1
  • McMaster University1

Top Investigators

Related Conditions

  • Obsessivecompulsive Disorder3
  • Obsessive Thoughts1
  • Obsessive Compulsive Behavior1

Activity Timeline